المؤلفون: Passaro, A, Wang, J, Wang, Y, Lee, S-H, Melosky, B, Shih, J-Y, Azuma, K, Juan-Vidal, O, Cobo, M, Felip, E, Girard, N, Cortot, AB, Califano, R, Cappuzzo, F, Owen, S, Popat, S, Tan, J-L, Salinas, J, Tomasini, P, Gentzler, RD, William, WN, Reckamp, KL, Takahashi, T, Ganguly, S, Kowalski, DM, Bearz, A, MacKean, M, Barala, P, Bourla, AB, Girvin, A, Greger, J, Millington, D, Withelder, M, Xie, J, Sun, T, Shah, S, Diorio, B, Knoblauch, RE, Bauml, JM, Campelo, RG, Cho, BC, MARIPOSA-2 Investigators

المساهمون: Popat, Sanjay

مصطلحات موضوعية: EGFR-mutated, NSCLC, amivantamab, lazertinib, post-osimertinib

جغرافية الموضوع: England

وصف الملف: Print-Electronic; S0923-7534(23)04281-3 -; application/pdf

العلاقة: S0923-7534(23)04281-3; Annals of Oncology, 2023, pp. S0923-7534(23)04281-3 -; https://repository.icr.ac.uk/handle/internal/6113Test

الإتاحة: https://doi.org/10.1016/j.annonc.2023.10.117Test
https://repository.icr.ac.uk/handle/internal/6113Test

المؤلفون: Passaro, A, Wang, J, Wang, Y, Lee, SH, Melosky, B, Shih, JY, Azuma, K, Juan-Vidal, O, Cobo, M, Felip, E, Girard, N, Cortot, AB, Califano, Raffaele, Cappuzzo, F, Owen, S, Popat, S, Tan, JL, Salinas, J, Tomasini, P, Gentzler, RD, William, WN., Jr, Reckamp, KL, Takahashi, T, Ganguly, S, Kowalski, DM, Bearz, A, MacKean, M, Barala, P, Bourla, AB, Girvin, A, Greger, J, Millington, D, Withelder, M, Xie, J, Sun, T, Shah, S, Diorio, B, Knoblauch, RE, Bauml, JM, Campelo, RG, Cho, BC

المساهمون: Department of Medical Oncology, Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, UK

العلاقة: https://dx.doi.org/10.1016/j.annonc.2023.10.117Test; Passaro A, Wang J, Wang Y, Lee SH, Melosky B, Shih JY, et al. Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study. Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Oct 23. PubMed PMID: 37879444. Epub 2023/10/26. eng.; http://hdl.handle.net/10541/626678Test; Annals of Oncology

الإتاحة: https://doi.org/10.1016/j.annonc.2023.10.117Test
http://hdl.handle.net/10541/626678Test

المؤلفون: Sandhu, S.K., Gotto, G., Vera-Badillo, F.E., Byun, S-S., Cutuli, H.J., Gomes, A.J.P.D.S., Helissey, C., Karsh, L.I., Peer, A., Preto, D.D., Pu, Y-S., Ravilla, R., Roubaud, G., Skoneczna, I.A., Kim, W., Espina, B., Withelder, M., Urtishak, K., Francis, P.S.J., Saad, F.

المصدر: Annals of Oncology ; volume 34, page S993 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2023.09.2783Test
https://api.elsevier.com/content/article/PII:S0923753423036207?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753423036207?httpAccept=text/plainTest

المؤلفون: Houts, CR¹ (AUTHOR), Savord, A¹ (AUTHOR), Gardner, M¹ (AUTHOR), Mattera, M² (AUTHOR), Peipert, J³ (AUTHOR), Agrawal, T⁴ (AUTHOR), Baig, M⁴ (AUTHOR), Barala, P⁴ (AUTHOR), Bauml, J⁴ (AUTHOR), Diorio, B⁴ (AUTHOR), Girvin, A⁴ (AUTHOR), Li, T⁴ (AUTHOR), Sermon, J⁵ (AUTHOR), Shah, S⁴ (AUTHOR), Withelder, M⁴ (AUTHOR), Wortman-Vayn, H⁴ (AUTHOR), Schuchard, J⁴ (AUTHOR)

المصدر: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS328-S328. 1p.